Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum93862Research ArticleNikotinzamestitel'naya terapiya v lechenii tabachnoy zavisimosti u patsientov s serdechno-sosudistymi zabolevaniyamiGambaryanM. G-15052013155515628122021Copyright © 2013, Consilium Medicum2013[Lopez A. Smoking and death in Russia. Tobacco Control 1998; 7: 3–4.][World Health Organization – NCD Country Profiles, 2011. http://www.who.int/nmh/countries/rus_en.pdf][Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988; 115: 242–9.][Шальнова С.А., Деев А.Д., Оганов Р.Г. Факторы, влияющие на смертность от сердечно - сосудистых заболеваний в российской популяции. Кардиоваск. терапия и профилактика. 2005; 4 (1): 4–9.][Rivers J.T, White H.D, Cross D.B et al. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: Incidence and effect of smoking. J Am Coll Cardiol 1990; 16; 340–8.][Balfour D, Benowitz N, Fagerstrom K et al. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. European Heart J 2000; 21: 438–45.][Iestra J.A et al. A systematic review. Circulation 2005; 112: 924–34.][Международная классификация болезней МКБ-10. Класс: психические расстройства и расстройства поведения. Блок: психические расстройства и расстройства поведения, связанные с употреблением психоактивных веществ. http://www.mkb10.ru/?class=5&bloc=65][Региональное бюро ВОЗ. Глобальный опрос взрослого населения о потреблении табака. РФ, 2009.][Giovino G.A, Henningfield J.E, Tomar S.L et al. Epidemiology of tobacco use and dependence. Epidem Rev 1995; 17: 48–65.][Hughes J.R, Gulliver S.B, Fenwick J.W et al. Smoking cessation among self - quitters. Health Psychol 1992; 11: 331–4.][Rigotti N.A, Singer D.E, Mulley A.G. Jr, Thibault G.E. Smoking cessation following admission to a coronary care unit. J Gen Intern Med 1991; 6: 305–11.][Jimenez-Ruiz C.A, Masa F, Miravitlles M et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119: 1365–70.][Walters N, Coleman T. Comparison of the smoking behaviour and attitudes of smokers who attribute respiratory symptoms to smoking with those who do not. Br J Gen Pract 2002; 52: 132–4.][Benowitz N.L. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med Vol. 2008; 121 (4): 3–10.][Dani J.A, De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 2001; 70: 439–46.][Nestler E.J. Is there a common molecular pathway for addiction? Nat Neurosci 2005; 8: 1445–9.][Benowitz N.L. Nicotine addiction. Prim Care 1999; 26: 611–31.][Wang H, Sun X. Desensitized nicotinic receptors in brain. Brain Res Brain Res Rev 2005; 48: 420–37.][Dani J.A, Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron 1996; 16: 905–8.][Brody A.L, Mandelkern M.A, London E.D et al. Cigarette smoking saturates brain a4b2 nicotinic acetylcholine receptors. Arch Gen Psychiat 2006; 63: 907–15.][Hughes J.R. Clinical significance of tobacco with drawal. Nicotine Tob Res 2006; 8: 153–6.][Tran K, Asakawa K, Cimon K et al. Pharmacologic - based strategies for smoking cessation: clinical and cost - effectiveness analyses. V. 2 (3). Cadth Technol Overv 2012; PMC 34426192010.][Henningfield J.E. Nicotine medications for smoking cessation. N Engl J Med 1995; 333: 1196–203.][Treating tobacco use and dependence: 2008 update. Tobacco use and dependence guideline panel. Rockville (MD): US Department of Health and Human Services 2008.][Stead L.F, Perera R, Bullen C et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; 14: 11. CD000146. doi: 10.1002/14651858. CD000146.pub4][Tonnesen R, Paoletti P, Gustavsson G et al. Higher dosage nicotine patches increase one - year smoking cessation rates: results from the European CEASE trial. Eur Resp J 1999; 13: 238–46.][Molyneux A, Lewis S, Leivers U et al. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax 2003; 58 (6): 484–8.][Treating tobacco use and dependence: 2008 update. Tobacco use and dependence guideline panel. Rockville (MD): US Department of Health and Human Services 2008.][Mills E.J, Wu P, Lockhart I et al. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta - analysis of one hundred and twenty studies involving 177,390 individuals. Tobacco Induced Diseas 2010; 8 (8). http://www.tobaccoinduceddiseases.com/content/8/1/8][Ottervanger J.P, Festen J.M, Vries de A.G, Stricker B.H. Acute myocardial infarction while using the nicotine patch. Chest 1995; 107: 1765–6.][Ropchan G.V, Sanfilippo A.J, Ford S.E. Aortic dissection and use of the nicotine patch: a case involving a temporal relationship. Can J Cardiol 1997; 13: 525–8.][Van der Klauw M.M, Van Hillo B, Van den Berg W.H et al. Vasculitis attributed to the nicotine patch (Nicotinell). Br J Dermatol 1996; 134: 361–4.][Dacosta A, Guy J.M, Tardy B et al. Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J 1993; 14: 1709–11.][Pierce J.R Jr. Stroke following application of a nicotine patch [letter]. Ann Pharmacother 1994; 28: 402.][Warner J.G Jr, Little W.C. Myocardial infarction in a patient who smoked while wearing a nicotine patch [letter]. Ann Intern Med 1994; 120: 695.][Riche G, Nighoghossian N, Trouillas P. Intracerebral haematoma after application of nicotine patch [letter]. Lancet 1995; 346: 777–8.][Mathew T.P, Herity N.A. Acute myocardial infarction soon after nicotine replacement therapy [letter]. QJM 2001; 94: 503–4.][Ford C.L, Zlabek J.A. Nicotine replacement therapy and cardiovascular disease mayo. Clin Proc 2005; 80 (5): 652–6.][Working group for the study of transdermal nicotine in patients with coronary artery disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154: 989–95.][Joseph A.M, Norman S.M, Ferry L.H et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335: 1792–8.][Greenland S, Satterfield M.H, Lanes S.F. A meta - analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf 1998; 18: 297–308.][Kimmel S.E, Berlin J.A, Miles C et al. Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol 2001; 37: 1297–302.][Antman E.M, Anbe D.T, Armstrong P.W et al. ACC/AHA guidelines for the management of patients with ST - elevation myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: 671–719.]